Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preference.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
12 2020
Historique:
received: 21 07 2020
accepted: 09 10 2020
revised: 05 01 2021
pubmed: 22 12 2020
medline: 30 1 2021
entrez: 21 12 2020
Statut: epublish

Résumé

Species belonging to the Mycobacterium tuberculosis Complex (MTBC) show more than 99% genetic identity but exhibit distinct host preference and virulence. The molecular genetic changes that underly host specificity and infection phenotype within MTBC members have not been fully elucidated. Here, we analysed RD900 genomic region across MTBC members using whole genome sequences from 60 different MTBC strains so as to determine its role in the context of MTBC evolutionary history. The RD900 region comprises two homologous genes, pknH1 and pknH2, encoding a serine/threonine protein kinase PknH flanking the tbd2 gene. Our analysis revealed that RD900 has been independently lost in different MTBC lineages and different strains, resulting in the generation of a single pknH gene. Importantly, all the analysed M. bovis and M. caprae strains carry a conserved deletion within a proline rich-region of pknH, independent of the presence or absence of RD900. We hypothesized that deletion of pknH proline rich-region in M. bovis may affect PknH function, having a potential role in its virulence and evolutionary adaptation. To explore this hypothesis, we constructed two M. bovis 'knock-in' strains containing the M. tuberculosis pknH gene. Evaluation of their virulence phenotype in mice revealed a reduced virulence of both M. bovis knock-in strains compared to the wild type, suggesting that PknH plays an important role in the differential virulence phenotype of M. bovis vs M. tuberculosis.

Identifiants

pubmed: 33347499
doi: 10.1371/journal.ppat.1009061
pii: PPATHOGENS-D-20-01575
pmc: PMC7785237
doi:

Substances chimiques

Bacterial Proteins 0
PknH protein, Mycobacterium tuberculosis EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009061

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
J Bacteriol. 2006 Apr;188(8):2936-44
pubmed: 16585755
Mol Microbiol. 2006 Dec;62(5):1251-63
pubmed: 17064366
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Trends Immunol. 2012 Jan;33(1):14-25
pubmed: 22094048
Tuberculosis (Edinb). 2006 Jan;86(1):20-7
pubmed: 16253563
Genome Announc. 2015 Oct 08;3(5):
pubmed: 26450718
J Exp Med. 2003 Sep 1;198(5):705-13
pubmed: 12953092
Genome Announc. 2017 Apr 6;5(14):
pubmed: 28385856
Microbes Infect. 2005 Mar;7(3):325-34
pubmed: 15804490
Appl Environ Microbiol. 2016 Apr 04;82(8):2240-2246
pubmed: 26850295
Mol Microbiol. 1999 May;32(3):643-55
pubmed: 10320585
J Bacteriol. 2012 May;194(9):2307-20
pubmed: 22389481
Tuberculosis (Edinb). 2016 Sep;100:46-52
pubmed: 27553409
Front Microbiol. 2017 Dec 05;8:2389
pubmed: 29259589
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Biol Chem. 2010 Sep 17;285(38):29239-46
pubmed: 20630871
Mol Microbiol. 1999 Mar;31(5):1573-87
pubmed: 10200974
Nat Microbiol. 2016 Jan 27;1:15019
pubmed: 27571976
Nature. 2010 Aug 19;466(7309):973-7
pubmed: 20725040
J Bacteriol. 2013 Jan;195(1):66-75
pubmed: 23104803
Microbiology (Reading). 2004 Jun;150(Pt 6):1681-1686
pubmed: 15184554
Infect Immun. 2009 Feb;77(2):598-603
pubmed: 19064634
PLoS Negl Trop Dis. 2012;6(2):e1552
pubmed: 22389744
Biochem J. 1994 Jan 15;297 ( Pt 2):249-60
pubmed: 8297327
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7877-82
pubmed: 12788972
Sci Rep. 2018 Jan 17;8(1):894
pubmed: 29343690
Clin Transl Med. 2017 Dec;6(1):21
pubmed: 28646367
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11491-6
pubmed: 25049399
Biochem Biophys Res Commun. 2007 Mar 30;355(1):162-8
pubmed: 17286964
Sci STKE. 2003 Apr 22;2003(179):RE8
pubmed: 12709533
Front Mol Biosci. 2020 Jan 08;6:149
pubmed: 31998747
Biochemistry. 2003 Dec 30;42(51):15300-9
pubmed: 14690440
Trends Microbiol. 2014 Oct;22(10):552-3
pubmed: 25174642
Innate Immun. 2020 May;26(4):240-247
pubmed: 31735099
Microbiology (Reading). 2013 Apr;159(Pt 4):726-736
pubmed: 23412844
Adv Exp Med Biol. 2017;1019:135-154
pubmed: 29116633
Chest. 2010 Jan;137(1):122-8
pubmed: 19749004
FEMS Microbiol Lett. 2004 Apr 1;233(1):107-13
pubmed: 15043876
Mol Microbiol. 2006 Jun;60(5):1109-22
pubmed: 16689789
Microb Genom. 2018 Mar;4(3):
pubmed: 29557774
J Vet Med Educ. 2003 Summer;30(2):140-2
pubmed: 12970858
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3684-9
pubmed: 11891304
Infect Immun. 1995 Sep;63(9):3428-37
pubmed: 7642273
Infect Immun. 2009 Oct;77(10):4631-42
pubmed: 19620341
J Bacteriol. 2005 Aug;187(16):5751-60
pubmed: 16077122
Nat Med. 2019 Feb;25(2):255-262
pubmed: 30664782
PLoS One. 2010 Jan 01;5(1):e8527
pubmed: 20049086
Infect Genet Evol. 2017 Sep;53:68-76
pubmed: 28434972
J Mol Microbiol Biotechnol. 2005;9(3-4):167-81
pubmed: 16415590
J Infect Dis. 2016 Mar 1;213(5):831-9
pubmed: 26494773
Nat Rev Microbiol. 2016 Nov;14(11):677-691
pubmed: 27665717
FASEB J. 2000 Feb;14(2):231-41
pubmed: 10657980
J Biol Chem. 2014 Jul 25;289(30):20422-33
pubmed: 24928517
Adv Exp Med Biol. 2017;1019:1-26
pubmed: 29116627
Infect Immun. 2005 Mar;73(3):1744-53
pubmed: 15731075

Auteurs

Elena Mata (E)

Grupo de Genética de Micobacterias, Universidad de Zaragoza/ISS Aragon, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.

Damien Farrell (D)

School of Veterinary Medicine, Veterinary Science Centre, University College Dublin, Dublin, Ireland.

Ruoyao Ma (R)

School of Veterinary Medicine, Veterinary Science Centre, University College Dublin, Dublin, Ireland.

Santiago Uranga (S)

Grupo de Genética de Micobacterias, Universidad de Zaragoza/ISS Aragon, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.

Ana Belen Gomez (AB)

Grupo de Genética de Micobacterias, Universidad de Zaragoza/ISS Aragon, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.

Marta Monzon (M)

Research Centre for Encephalopathies and Transmissible Emerging Diseases, Universidad de Zaragoza, Zaragoza, Spain.

Juan Badiola (J)

Research Centre for Encephalopathies and Transmissible Emerging Diseases, Universidad de Zaragoza, Zaragoza, Spain.

Alberto Anel (A)

Grupo Apoptosis, Inmunidad y Cáncer, IIS Aragón. Dpto. Bioquímica y Biología Molecular y Celular, Fac. Ciencias, Universidad de Zaragoza, Zaragoza, Spain.

Jesús Gonzalo-Asensio (J)

Grupo de Genética de Micobacterias, Universidad de Zaragoza/ISS Aragon, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Instituto de Biocomputación y Física de Sistemas Complejos (BIFI), Zaragoza, Spain.

Carlos Martin (C)

Grupo de Genética de Micobacterias, Universidad de Zaragoza/ISS Aragon, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Servicio de Microbiología, Hospital Universitario Miguel Servet, ISS Aragon, Spain.

Stephen V Gordon (SV)

School of Veterinary Medicine, Veterinary Science Centre, University College Dublin, Dublin, Ireland.

Nacho Aguilo (N)

Grupo de Genética de Micobacterias, Universidad de Zaragoza/ISS Aragon, Zaragoza, Spain.
CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH